Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EXEL · against 454 other Healthcare companies listed in US-listed
Ranked #209 of 455 · scores higher than 53% of peers
Bars: peers in each 10-point band of the growth score46 peers with a growth score of 60–69, including EXEL · Click a bar to see the companies
Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | EXEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 9.2% | 11.0% | 46% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 55.2% | 21.2% | 68% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 12.4% | 11.0% | 53% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 204 | 4.0B USD | 69 | 56 | |
| 204 | 504M USD | 69 | 24 | |
| 204 | 49.1B USD | 69 | 69 | |
| 209 | 773M USD | 68 | 64 | |
| 209 | 17.9B USD | 68 | 76 | |
| 209 | 34.6B USD | 68 | 58 | |
| 209 | 2.6B USD | 68 | 66 | |
| 209 | 22M USD | 68 | 47 | |
| 214 | 2.5B USD | 67 | 79 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score